VP 16-213 in acute myelogenous leukaemia.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011034:Podophyllotoxin / Q000627:therapeutic use*; D012075:Remission, Spontaneous
D005047:Etoposide; D011034:Podophyllotoxin